Final Results Of A Translational Phase L Study Assessing A Qod Schedule Of The Potent Akt Inhibitor Mk-2206 Incorporating Predictive, Pharmacodynamic (Pd), And Functional Imaging Biomarkers.

JOURNAL OF CLINICAL ONCOLOGY(2011)

引用 9|浏览18
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要